





Eye is the organ responsible for the vision, which is considered one of the most 
important sense of human being.  Retina is the inner most layer at the posterior part of the 
eyeball which is a clear, thin, and photosensitive tissue. This structure converts light into 
electrical signals which is enabled by specialized cells, the photoreceptors, in a process 
termed phototransduction. There are two types of photoreceptors cells: rods and cones, which 
are located in humans in the peripheral and central retina, respectively. Rod cells are involved 
in the dim light vision while cone cells are associated with color detailed vision. In addition to 
the photoreceptors, retinal pigmented epithelium cells also play an important role in 
maintaining retinal function. (Figure 1) Losing either one or both of these photoreceptors as 
well as retinal pigment epithelium lead to a condition called retinal dystrophies.
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There are many types of retinal dystrophies, affecting only one cell type or both and 
different progression with age. These disorder phenotype range from achromatopsia, 
Stargardt’s disease, cone dystrophy, cone-rod dystrophy, retinitis pigmentosa, to Leber 
congenital amaurosis. (Figure 2) Amongst others, Leber congenital amaurosis is one of the 




Figure 1. Anatomy of the eye and retinal structure. Structure of the eye and the retina, which consists of 









Figure 2. Classification of IRDs according to age progression and cell involvement. There are two kind of 
photoreceptor cells involvement: rod and cone. Rod is responsible for dim light and peripheral vision. Cone is 
responsible for color and central vision. STGD: Stargardt disease, CD: cone dystrophy, ACHM: achromatopsia, 
CRD: cone-rod dystrophy, RP: retinitis pigmentosa, LCA: Leber congenital amaurosis.
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 (Adapted from: den 
Hollander, et al. 2010) 
 
2.1. Leber Congenital Amaurosis 
Leber congenital amaurosis (LCA; OMIM 204000) is the most severe retinal 
dystrophy with the early onset in the first year of life. It was described for the first time by the 
German doctor, Theodore Leber, in 1869. He found that the disease was characterized by 
unresponsive pupil, wandering nystagmus, and a fundus that initially appears normal and then 
turn to be typical for retinitis pigmentosa in early childhood. He introduced this disease as the 
congenital form of retinitis pigmentosa.
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 Pinckers thought that the disease Leber found 
actually was more or less the same as what we call now as neuronal ceroid lipofuscinosis.
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2.1.1. Clinical Characteristics 
The three main features of LCA are congenital onset of visual loss, amaurotic pupils; 
no response in light reflex, and nystagmus.
11
 Franceschetti and Dieterle mentioned the 
importance of elecroretinogram in retinal degeneration.
15
 Absent electroretinogram became 
one of the diagnostic criteria other than bilateral congenital blindness.
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 Foxman and 




Visual acuity in patients with LCA varies extensively. Typically from 20/200 to only 
light perception (LP) or negative LP.
1
 Studies from 90 LCA patients showed that the majority 
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(75%) of visual acuity of the patients remained stable while visual deterioration and even 




Table 1. Fundus photography results of LCA patients with known mutations in 
causative genes.1 
Genotype Fundus Photography 
AIPL1 (P.Thr124Ile/p.Pro376Ser) Macular coloboma, retinal arteriolar 
narrowing, and optic disc pallor 
CEP290 (p.Cys998*/p.Cys998*) Choroidal sclerosis, pale optic discs, 
non-visible retinal vessels, relative 
preservation of the posterior pole 
CRB1 (p.Cys948Tyr/p.Cys948Tyr) Preserved para-arteriolar RPE 
(PPRPE) and nummular pigmented 
retina 
CRX (p.Pro9fs*/+) Maculopathy, relatively normal 
appearing vessels and optic disc 
GUCY2D (p.Leu954Pro/p.Ser981fs) Relatively normal retinal appearance 
LCA5 (g.19612-18015del1598/g.19612-18015del1598) Optic disc drusen and mild vessels 
narrowing 
LRAT (p.Met73fs*/p.Met73fs*) Mild vessel narrowing and very mild 
salt and pepper appearance with 
normal optic disc 
RDH12 (p.Cys285Tyr/p.Cys285Tyr) Maculopathy 
RPE65 (p.Tyr368His/p.Tyr368His) RPE translucency 
RPGRIP1 (p.Arg89*/ p.Arg89*) Bone spicules appearance and vessel 
dragging 
TULP1 (c.718+2T>C/c.718+2T>C) Perivofeal yellow annular ring and 
mild pigmentary changes 
All LCA patients in this table have recessive mutations, except for the patient with CRX mutation. 
 
Fundus photography of the retina from LCA patients reveal an extensive disparity, 
from basically unaffected retina, to retinal arteriolar narrowing, retinal pigmentation (bone 
spicule, salt and pepper, or nummular), and maculopathy (Table 1). A study showed a 
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correlation between preserved para-arteriolar RPE and CRB1 LCA-causing mutation. 
However, it is still difficult to have a convincing genotype-phenotype correlation in IRDs.
1,21
 
ERG is essential to assess the visual function of LCA patients. ERG serves to measure 
the function of cone and rod cells. The electrical signal a-wave comes from the photoreceptor 
and the b-wave comes from bipolar and Müller cells. ERG test shows nonresponsive signals 
in LCA patients while a-wave and b-wave are detectable in normal persons. This is especially 
important to diagnose LCA and also to figure out the genotype-phenotype correlation in LCA. 
Some studies showed that LCA patients carrying mutations in AIPL1 have a rod ERG 
impairment, in GUCY2D cone ERG impairment, and in RPGRIP1 both cone and rod 
impairment. Carriers with CRB1 heterozygous mutation may develop regional retinal 
dysfunction that can be determined using multi-focal ERG.
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Clinical characteristics are also important in order to understand, characterize, and 
predict the prognosis of the disease. While fundus photography provides a wide variety of 
retinal appearances, full-field ERGs never give positive results after treatment in previous 
study.
22
 Pupillometry and nystagmus assessment were used as an objective measurement in 
clinical trial of LCA patients. Still, subjective measurements such as best corrected visual 




2.1.2 Genetic Causes and Heritability of Leber Congenital Amaurosis 
There are different approaches to identify the genetic causes of LCA such as linkage analysis, 
identity-by-descent (IBD) mapping, candidate gene analysis and whole exome sequencing 
(Table 2). 
 





















Locus identified LCA9 on 1p36, 
LCA3 on 14q24 
- - - 
Several methods were used as a mutation identification strategy. This allowed scientist to design cost-effective 
research based on available facilities. 
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Table 3. Prevalence of LCA causative genes.
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Gene Location Protein  Prevalence 
GUCY2D 17p13.1 Retinal-specific guanylate cyclase 6%-21% 
CEP290 12q21.32 Centrosomal protein 290 kDa ~20% 
RPE65 1p31.2 Retinal pigment epithelium-specific 65 kD protein 3%-16% 
CRB1 1q31.3 Crumbs homolog 1 9-13% 
AIPL1 17p13.2 Arylhydrocarbon-interacting receptor protein-like 1 4%-8% 
RPGRIP1 14q11.2 RP GTPase regulator-interacting protein 1 ~5% 
RDH12 14q24.1 Retinol dehydrogenase 12 ~4% 
CRX 19q13.32 Cone-rod OTX-like photoreceptor homeobox 
transcription factor 
~3% 
LCA5 6q14.1 Lebercilin 1%-2% 
SPATA7 14q31.3 Spermatogenesis associated protein 7 Unknown 
NMNAT1 1p36.22 Nicotinamide nucleotide adenylyl transferase 1 Unknown 
IMPDH1 7q32.1 Inosine monophosphat dehidrogenase 1  
RD3 1q32.3 RD3 protein Unknown 
LRAT 4q32.1 Lecithin retinol acyltranseferase Unknown 
TULP1 6p21.31 Tubby-like protein 1 Unknown 
KCNJ13 2q37 Inwardly-rectifying potassium channel subfamily J 
member 13 
Unknown 
IQCB1 3q13.33 IQ motif containing B1 protein Unknown 
OTX2 14q22.3 Orthodenticle homeobox 2 protein Unknown 
CABP4 11q13.1 Calcium binding protein 4 Unknown 
DTHD1 4p14 Death domain containing protein 1 Unknown 
GDF6 8q22.1 Growth differentiation factor 6 Unknown 
MERTK 2q14.1 c-mer protooncogen receptor tyrosine kinase Unknown 
So far, 22 genes have been identified to cause LCA. Around 70% was caused by mutation in GUCY2D, CEP290, 
RPE65, CRB1, and AIPL1. 
 
Since most of LCA’s causative genes are inherited recessively, non-consanguineous 
families with at least 6 patients are needed to reach significance in linkage analysis. Only 3-4 
patients are required for significant linkage analysis in consanguineous families. Furthermore, 
IBD mapping can be used in families with small size that are not reaching significance by 
linkage analysis. Candidate gene analysis can be used because non-syndromic LCA is 
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restricted to retina, therefore, genes that are expressed specifically in retina or have important 
function, can be presumed as candidate genes for LCA.
1
 
Thus far, there are up to 22 genes involved in this disease (Table 3).
6
 From those 
genes, CEP290, GUCY2D, CRB1, IMPDH1, and RPE65 are the most common mutated 
genes, with a prevalence being 15%, 11.7%, 9.9%, 8.3%, and 6%, respectively in previous 
studies on Caucasian populations. Since there is no comprehensive data about Asian 
population, it is important to accomplish the study. Inheritance pattern of LCA is mainly 
autosomal recessive, apart from CRX, IMPDH1, OTX which can be inherited in an autosomal 
dominant trait. These genes can be clustered into several group based on the mechanism in 
which they are involved: phototransduction, retinoid cycle, photoreceptor structure and 





2.1.3 CEP290  
CEP290 is one of the most mutated genes in LCA (~20%) in Caucasian populations. 
This gene encodes the centrosomal protein of 290 kDa composed of 2472 amino acids. This 
protein is localized in the connecting cilium of the retinal photoreceptor cells, which may play 
a role in the transport system between the inner and outer segment of the photoreceptors. This 
transport system is very important because the proteins, which required for phototransduction, 
are synthesized in the inner segment of the photoreceptor cells. These proteins have to be 
transported to the outer segment, in order to conduct their correct function. In addition, 
CEP290 is expressed in almost all of the body cells localizing to the centrosomes or the basal 
body of the cilium. Cilium is a microtubule-related organelle which acts as the antenna of the 
cells, transferring sensory information from the extracellular surroundings. The importance of 




Mutations in CEP290 result in a wide range of ciliopathies (Figure 3): LCA, Senior-
Loken syndrome (SLS), Joubert syndrome and related disorder (JSRD), cerebello-oculo-renal 
syndrome (CORS), Meckel-Gruber syndrome (MKS), MKS-like, Bardet-Biedl syndrome.
1,26
 





Figure 3. Mutation spectrum in CEP290. CORS: Cerebello-oculo-renal syndrome, JS: Joubert syndrome, 
JS+RF: Joubert syndrome plus renal failure, LCA: Leber congenital amaurosis, MKS: Meckel-Gruber syndrome, 
BBS: Bardet-Biedl syndrome, MKS-like: Meckel-Gruber like syndrome, SLS: Senior-Loken syndrome. 





2.2. Therapeutic Strategies 
Therapeutic strategies for inherited retinal disorders comprise gene augmentation 
therapy and antisense oligonucleotide-based therapy. Nucleic acid sequence, either DNA or 
RNA, is used for both of them rather than protein or other molecules. The therapeutic agent is 
delivered to the target cells and allows restoration of gene function by acting as a replacement 




2.2.1 Gene Augmentation Therapy 
Gene augmentation therapy aims to insert a full-length cDNA of a gene, to restore the 
defect caused by the mutation. As the full-length cDNA is insufficient to enter the cell itself, 
the presence of a vector is required. There are several vectors available for gene augmentation 




Clinical trials for RPE65-associated LCA have already been conducted using adeno-
associated virus (AAV) vector containing the full length RPE65 cDNA. This approach was 




2.2.1.1 Lentiviral Vector 
Lentivirus (LV) is a single-strand RNA retrovirus enable to infect both dividing and 
non-dividing cells and can be integrated in the chromosome of host cells. This ability gives a 
benefit of a long-term expression in dividing cells. However, random insertion of LV in the 
gene and gene spare long interspersed nuclear elements (LINE) can cause insertional 
mutagenesis which can lead to other genetic diseases such as cancer. In addition, expression 
levels can be reduced because of moderate immune response. The cargo capacity of this virus 




2.2.1.2 Adeno-associated Viral Vector 
Adeno-associated virus (AAV) is a single strand DNA Dependovirus which is 
favorable in IRD gene therapy due to their ability to target various retinal layers with 
relatively safety and immunogenicity profile. One of the AAV’s major strength is the 
availability of many serotypes and the ability to create hybrid vectors with the same AAV 
inverted terminal repeats (ITRs) and the capsid from different variant (Table 5). This 





Table 4. Vectors used in clinical trial for various retinal diseases. (Adapted from: Rowe-
Rendleman, et al. 2014) 








Choroideremia rAAV2.REP1 Intraocular 





AMD AdGVPEDE11D Intraocular 
Stargardt disease StarGen equine infectATious 
anemia virus (EIAV) 
lentiviral vector expressesing 
ABCA4 
Intraocular 
AMD RetinoStat EIAV lentiviral 
vector expressing endostatin 
and angiostatin 
Intaocular 
RP with Usher syndrome UshStat EIAV lentiviral 
vector expressing MYO7A 
Intaocular 
AMD AAV2-sFLT01 Intaocular 
Retinal disease rAAV2-VMD2-Hmertk Intaocular 
Metastatic melanoma of the 
eye 
Albumin nanoparticles Systemic 
Diabetic macular edema Cyclodextrin microparticles Topical 
Abbreviation: rAAV, recombinant adeno-associated virus. hRPE65, human Retinal pigmented Epithelium 65 
kDa. CB, Chicken Beta-actin. REP1, Rab Escort Protein 1. siRNA, small-interference RNA. sFLT01, soluble 
Fms-like tyrosine kinase. MYO7A, Myosin VIIA. VMD2, Vitelliform Macular Dystrophy 2. hMERTK, human 
c-mer Proto-Oncogen Tyrosine Kinase. AMD, Age-related Macular Degeneration. RP, retinitis pigmentosa. 
 
Despite of the versatility, AAV has a limited cargo capacity (4.7 kb). This constraint 
limits the use of AAV in IRD caused by mutation in genes whose cDNA exceeds 5 kb, for 




and packing them separately in two different AAV (dual AAV vectors). Dual AAV vectors 












Virion Target Tissue 
Rep 2 Cap 1 AAV2/1 Muscle, Retinal 
pigment epithelium 
(RPE), Lung 
Rep 2 Cap 2  AAV2/2 Muscle, Liver, Retina 
Rep 2 Cap 3 AAV2/3 Inner ear 
Rep 2 Cap 4 AAV2/4 SNc, RPE 
Rep 2 Cap 5 AAV2/5 Lung, Retina 
Rep 2 Cap 7 AAV2/7 Muscle, Retina 
Rep 2 Cap 8 AAV2/8 Liver, Retina 
Rep 2 Cap 9 AAV2/9 Lung, Heart, SNc 
Abbreviations: Rep, Replication. Cap, Capsid. AAV packaging plasmid can be used to target different organs. 
 
2.2.1.3 Nanoparticles 
Nanoparticles (NP) have been tested for IRD since it provides relatively large cargo 
capacity (up to 20 kb) and no insertional mutagenesis. NP are peptides for ocular delivery 
(POD), which can enter retinal cells in vivo. CK30PEG-NP is a POD conjugated with 
polyethylene glycol.
37
 CK30PEG-NP can be used to transfer ABCA4 in Stargardt’s mouse 




2.2.2 Antisense Oligonucleotide Based Therapy 
Antisense oligonucleotide (AON) is a small (13-25 bp) RNA molecule that bind to a 
specific sequence of the pre-mRNA, manipulating the splicing mechanism.
39,40 
Nonetheless, 
these molecules are easily degraded by ribonucleases, therefore, chemical modifications to 
increase the intracellular stability are important. The specificity and stability of AONs are 






2.2.2.1 AON Sequences 
Theoretically, AON sequences are specifically designed to induce a biological effect, 
such as interfering expression of interest gene via RNase H-dependent mechanism or 
manipulating aberrant transcript caused by splicing mutation. Basically, two groups of AON 
are known: RNase H-dependent oligonucleotides, which degrade mRNA, and sterick-blocker 
oligonucleotides, which interfere with the splicing machinery. Both of them need to be 
specific, but the action mechanism of AON itself is complex and poorly understood. Several 
predictive tools have been established, mostly based on the secondary structures of local 
sequences and thermodynamic properties of AONs. One of them is ESEfinder 
(http://rulai.cshl.edu/cgibin/tools/ESE3/esefinder.cgi?process=home), which has been used in 




2.2.2.2 Chemical Structure of AON 
Phosphorothioate is the most widely used antisense oligonucleotide backbone, which 
is more soluble than methylphosphonates, the first synthesized oligonucleotides backbones. 
Modification are also important in the 2’-position of ribose by an O-alkyl group to enhance 
the stability of AONs inside the cell without decreasing the potency, such as 2’-methoxy (2’-
OMe) and 2’-methoxyethoxy (2’-MOE) (Figure 4). The stability of these modifications 
probably due to the structural protection provided by the alkyl group.
40 
However, convincing 





Figure 4. Chemical structure of AON. Adapted from: http://www.atdbio.com/content/13/Oligonucleotides-as-
drugs. This study used two kinds of modification in O-alkyl group. 
 
